Global Biologic Drugs Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
Date: Apr-2021 | Id: MACRC-64329 | Geographical Scope: Global | Publisher: Mnemonics Research
The global Biologic Drugs market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on Mnemonics Rresearch newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: Roche Abbott Laboratories Johnson & Johnson Merck & Co. Pfizer Amgen Sanofi Novartis Eli Lilly Amgen By Types: Humira Remicade Rituxan Enbrel Lantus Avastin Herceptin Others By Applications: Diabetes Inflammation Auto-Immune Diseases Blood Diseases Cardiovascular Diseases Others Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Biologic Drugs Revenue 1.5 Market Analysis by Type 1.5.1 Global Biologic Drugs Market Size Growth Rate by Type: 2021 VS 2027 1.5.2 Humira 1.5.3 Remicade 1.5.4 Rituxan 1.5.5 Enbrel 1.5.6 Lantus 1.5.7 Avastin 1.5.8 Herceptin 1.5.9 Others 1.6 Market by Application 1.6.1 Global Biologic Drugs Market Share by Application: 2022-2027 1.6.2 Diabetes 1.6.3 Inflammation 1.6.4 Auto-Immune Diseases 1.6.5 Blood Diseases 1.6.6 Cardiovascular Diseases 1.6.7 Others 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Biologic Drugs Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter’s Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Biologic Drugs Market Players Profiles 3.1 Roche 3.1.1 Roche Company Profile 3.1.2 Roche Biologic Drugs Product Specification 3.1.3 Roche Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.2 Abbott Laboratories 3.2.1 Abbott Laboratories Company Profile 3.2.2 Abbott Laboratories Biologic Drugs Product Specification 3.2.3 Abbott Laboratories Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.3 Johnson & Johnson 3.3.1 Johnson & Johnson Company Profile 3.3.2 Johnson & Johnson Biologic Drugs Product Specification 3.3.3 Johnson & Johnson Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 Merck & Co. 3.4.1 Merck & Co. Company Profile 3.4.2 Merck & Co. Biologic Drugs Product Specification 3.4.3 Merck & Co. Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 Pfizer 3.5.1 Pfizer Company Profile 3.5.2 Pfizer Biologic Drugs Product Specification 3.5.3 Pfizer Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 Amgen 3.6.1 Amgen Company Profile 3.6.2 Amgen Biologic Drugs Product Specification 3.6.3 Amgen Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 Sanofi 3.7.1 Sanofi Company Profile 3.7.2 Sanofi Biologic Drugs Product Specification 3.7.3 Sanofi Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.8 Novartis 3.8.1 Novartis Company Profile 3.8.2 Novartis Biologic Drugs Product Specification 3.8.3 Novartis Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.9 Eli Lilly 3.9.1 Eli Lilly Company Profile 3.9.2 Eli Lilly Biologic Drugs Product Specification 3.9.3 Eli Lilly Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.10 Amgen 3.10.1 Amgen Company Profile 3.10.2 Amgen Biologic Drugs Product Specification 3.10.3 Amgen Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Biologic Drugs Market Competition by Market Players 4.1 Global Biologic Drugs Production Capacity Market Share by Market Players (2016-2021) 4.2 Global Biologic Drugs Revenue Market Share by Market Players (2016-2021) 4.3 Global Biologic Drugs Average Price by Market Players (2016-2021) 5 Global Biologic Drugs Production by Regions (2016-2021) 5.1 North America 5.1.1 North America Biologic Drugs Market Size (2016-2021) 5.1.2 Biologic Drugs Key Players in North America (2016-2021) 5.1.3 North America Biologic Drugs Market Size by Type (2016-2021) 5.1.4 North America Biologic Drugs Market Size by Application (2016-2021) 5.2 East Asia 5.2.1 East Asia Biologic Drugs Market Size (2016-2021) 5.2.2 Biologic Drugs Key Players in East Asia (2016-2021) 5.2.3 East Asia Biologic Drugs Market Size by Type (2016-2021) 5.2.4 East Asia Biologic Drugs Market Size by Application (2016-2021) 5.3 Europe 5.3.1 Europe Biologic Drugs Market Size (2016-2021) 5.3.2 Biologic Drugs Key Players in Europe (2016-2021) 5.3.3 Europe Biologic Drugs Market Size by Type (2016-2021) 5.3.4 Europe Biologic Drugs Market Size by Application (2016-2021) 5.4 South Asia 5.4.1 South Asia Biologic Drugs Market Size (2016-2021) 5.4.2 Biologic Drugs Key Players in South Asia (2016-2021) 5.4.3 South Asia Biologic Drugs Market Size by Type (2016-2021) 5.4.4 South Asia Biologic Drugs Market Size by Application (2016-2021) 5.5 Southeast Asia 5.5.1 Southeast Asia Biologic Drugs Market Size (2016-2021) 5.5.2 Biologic Drugs Key Players in Southeast Asia (2016-2021) 5.5.3 Southeast Asia Biologic Drugs Market Size by Type (2016-2021) 5.5.4 Southeast Asia Biologic Drugs Market Size by Application (2016-2021) 5.6 Middle East 5.6.1 Middle East Biologic Drugs Market Size (2016-2021) 5.6.2 Biologic Drugs Key Players in Middle East (2016-2021) 5.6.3 Middle East Biologic Drugs Market Size by Type (2016-2021) 5.6.4 Middle East Biologic Drugs Market Size by Application (2016-2021) 5.7 Africa 5.7.1 Africa Biologic Drugs Market Size (2016-2021) 5.7.2 Biologic Drugs Key Players in Africa (2016-2021) 5.7.3 Africa Biologic Drugs Market Size by Type (2016-2021) 5.7.4 Africa Biologic Drugs Market Size by Application (2016-2021) 5.8 Oceania 5.8.1 Oceania Biologic Drugs Market Size (2016-2021) 5.8.2 Biologic Drugs Key Players in Oceania (2016-2021) 5.8.3 Oceania Biologic Drugs Market Size by Type (2016-2021) 5.8.4 Oceania Biologic Drugs Market Size by Application (2016-2021) 5.9 South America 5.9.1 South America Biologic Drugs Market Size (2016-2021) 5.9.2 Biologic Drugs Key Players in South America (2016-2021) 5.9.3 South America Biologic Drugs Market Size by Type (2016-2021) 5.9.4 South America Biologic Drugs Market Size by Application (2016-2021) 5.10 Rest of the World 5.10.1 Rest of the World Biologic Drugs Market Size (2016-2021) 5.10.2 Biologic Drugs Key Players in Rest of the World (2016-2021) 5.10.3 Rest of the World Biologic Drugs Market Size by Type (2016-2021) 5.10.4 Rest of the World Biologic Drugs Market Size by Application (2016-2021) 6 Global Biologic Drugs Consumption by Region (2016-2021) 6.1 North America 6.1.1 North America Biologic Drugs Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Biologic Drugs Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Biologic Drugs Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Biologic Drugs Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Biologic Drugs Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Biologic Drugs Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Biologic Drugs Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Biologic Drugs Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Biologic Drugs Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Biologic Drugs Consumption by Countries 7 Global Biologic Drugs Production Forecast by Regions (2022-2027) 7.1 Global Forecasted Production of Biologic Drugs (2022-2027) 7.2 Global Forecasted Revenue of Biologic Drugs (2022-2027) 7.3 Global Forecasted Price of Biologic Drugs (2022-2027) 7.4 Global Forecasted Production of Biologic Drugs by Region (2022-2027) 7.4.1 North America Biologic Drugs Production, Revenue Forecast (2022-2027) 7.4.2 East Asia Biologic Drugs Production, Revenue Forecast (2022-2027) 7.4.3 Europe Biologic Drugs Production, Revenue Forecast (2022-2027) 7.4.4 South Asia Biologic Drugs Production, Revenue Forecast (2022-2027) 7.4.5 Southeast Asia Biologic Drugs Production, Revenue Forecast (2022-2027) 7.4.6 Middle East Biologic Drugs Production, Revenue Forecast (2022-2027) 7.4.7 Africa Biologic Drugs Production, Revenue Forecast (2022-2027) 7.4.8 Oceania Biologic Drugs Production, Revenue Forecast (2022-2027) 7.4.9 South America Biologic Drugs Production, Revenue Forecast (2022-2027) 7.4.10 Rest of the World Biologic Drugs Production, Revenue Forecast (2022-2027) 7.5 Forecast by Type and by Application (2022-2027) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027) 7.5.2 Global Forecasted Consumption of Biologic Drugs by Application (2022-2027) 8 Global Biologic Drugs Consumption Forecast by Regions (2022-2027) 8.1 North America Forecasted Consumption of Biologic Drugs by Country 8.2 East Asia Market Forecasted Consumption of Biologic Drugs by Country 8.3 Europe Market Forecasted Consumption of Biologic Drugs by Countriy 8.4 South Asia Forecasted Consumption of Biologic Drugs by Country 8.5 Southeast Asia Forecasted Consumption of Biologic Drugs by Country 8.6 Middle East Forecasted Consumption of Biologic Drugs by Country 8.7 Africa Forecasted Consumption of Biologic Drugs by Country 8.8 Oceania Forecasted Consumption of Biologic Drugs by Country 8.9 South America Forecasted Consumption of Biologic Drugs by Country 8.10 Rest of the world Forecasted Consumption of Biologic Drugs by Country 9 Global Biologic Drugs Sales by Type (2016-2027) 9.1 Global Biologic Drugs Historic Market Size by Type (2016-2021) 9.2 Global Biologic Drugs Forecasted Market Size by Type (2022-2027) 10 Global Biologic Drugs Consumption by Application (2016-2027) 10.1 Global Biologic Drugs Historic Market Size by Application (2016-2021) 10.2 Global Biologic Drugs Forecasted Market Size by Application (2022-2027) 11 Global Biologic Drugs Manufacturing Cost Analysis 11.1 Biologic Drugs Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Biologic Drugs 12 Global Biologic Drugs Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Biologic Drugs Distributors List 12.3 Biologic Drugs Customers 12.4 Biologic Drugs Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Related reports
Pharmaceutical Grade Sodium Chloride Market
$2850-$4575
Adenosine Triphosphate ATP Test Kit Market
$3300-$7000
Alpha 1 Antitrypsin Deficiency Treatment Market
$3300-$7000